Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
about
International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy ModelEfficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials.Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany.House dust mite sublingual tablet is effective and safe in patients with allergic rhinitisAllergen extracts for immunotherapy: to mix or not to mix?Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents.SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.Investigational new drugs for allergic rhinitis.Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.Immunotherapy of house dust mite allergy.Advances in environmental and occupational disorders in 2016.Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trials.SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroupsSublingual allergen immunotherapy for respiratory allergy: a systematic reviewRecent advances in allergic rhinitisDuration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
P2860
Q33572979-245E4EA4-146E-4749-BB6B-C615D02D208FQ36256005-393B2A79-8E1A-4303-9350-A707400CB287Q36308157-F7091D7B-3003-4B33-9364-03DBB118D086Q37652877-1478C51B-3B87-4478-A3E4-14BEE682D22BQ37663911-A6843402-0DFD-454C-B4E7-3B5B5F56382EQ38664847-F99FD4E5-ADE1-41D9-93FC-67F5BC6BFAE8Q38703027-639084B4-BE78-4846-9EE4-5338363A38C7Q38703818-A36DFFEA-6C05-43EC-A410-8937E5CEBB78Q38745619-28BA6F6C-14BD-46EB-9AF1-A02A38CFAFE3Q38792200-7BDDF10D-6598-406F-B45E-20A752621191Q38837264-83B4C020-7FCE-4077-B62B-5FE1B5603D9FQ38870647-3D48E0C3-7BA0-476A-A4AB-7021EB583B90Q38888019-9D992EE3-3C18-4DC8-9D86-5424FDA2C8F5Q38955332-89BB70ED-AAB1-468B-8D56-12BCF0DE9603Q39111947-47708D4A-676F-431B-A866-C672B061CC3AQ40108188-67FC13E5-4535-4A65-88AC-717F0FC7A080Q43915564-A4AF509E-8746-40DC-96DB-B8222170EA34Q47596939-D6DBD6C5-72A2-4F5A-94AF-82B63C045A88Q47741028-1BADB6A4-B237-4280-A665-DF9349F9A60FQ47761576-CEE6DE2C-67B4-4E98-BD7C-E2FB3DDB3D39Q47764778-17CE4CBB-DD0B-4E55-BCF6-C41D787E7801Q47940422-FCC59AC6-7618-4D77-8E45-95E3E411A7A1Q52841094-F2311043-4134-4726-A91B-696AD00DCB71Q53714415-DEE99CEE-686D-4595-9705-FF481C4B93E7Q57193203-894C7184-26E5-4B3D-9191-A10EEDFBEE5AQ58700135-BD4318C8-15DA-47A7-9B1B-6716BBA240FAQ58713853-CC290916-5D8D-4C28-868C-BABD4D8A44C4Q58780229-83CCD230-E5FF-4CF9-B425-9A86B9567CA0
P2860
Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effective treatment of house d ...... bo-controlled phase III trial.
@en
type
label
Effective treatment of house d ...... bo-controlled phase III trial.
@en
prefLabel
Effective treatment of house d ...... bo-controlled phase III trial.
@en
P2093
P1476
Effective treatment of house d ...... bo-controlled phase III trial.
@en
P2093
Dorte Rehm
Jörg Kleine-Tebbe
Lene Tommerup
Pascal Demoly
Waltraud Emminger
P304
444-451.e8
P356
10.1016/J.JACI.2015.06.036
P407
P577
2015-08-17T00:00:00Z